Item Type | Name |
Concept
|
RNA, Viral
|
Academic Article
|
Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
|
Academic Article
|
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
|
Academic Article
|
Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.
|
Academic Article
|
High prevalence of hepatitis G virus RNA and antibody to probable viral envelope protein but not both in AIDS patients' plasma.
|
Academic Article
|
Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
|
Academic Article
|
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.
|
Academic Article
|
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
|
Academic Article
|
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.
|
Academic Article
|
Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.
|
Academic Article
|
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection.
|
Academic Article
|
Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function.
|
Academic Article
|
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
|
Academic Article
|
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.
|
Academic Article
|
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.
|
Academic Article
|
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.
|
Academic Article
|
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.
|
Academic Article
|
HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.
|
Academic Article
|
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication.
|
Academic Article
|
Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals.
|
Academic Article
|
Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Adult AIDS Clinical Trials Group 285 Study Team.
|
Academic Article
|
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads.
|
Academic Article
|
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine.
|
Academic Article
|
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
|
Academic Article
|
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
|
Academic Article
|
Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy.
|
Academic Article
|
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
|
Academic Article
|
Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load.
|
Academic Article
|
IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
|
Academic Article
|
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
|
Academic Article
|
Recent observations on HIV type-1 infection in the genital tract of men and women.
|
Academic Article
|
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial.
|
Academic Article
|
Role of Baseline pol Genotype in HIV-1 Fitness Evolution.
|
Academic Article
|
The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.
|
Academic Article
|
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study.
|
Academic Article
|
HIV type 1 and cytomegalovirus coinfection in the female genital tract.
|
Academic Article
|
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.
|
Academic Article
|
Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
|
Academic Article
|
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course.
|
Academic Article
|
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.
|
Academic Article
|
Hepatitis G virus RNA is common in AIDS patients' plasma but is not associated with abnormal liver function tests or other clinical syndromes.
|
Academic Article
|
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
|
Academic Article
|
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
|
Academic Article
|
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.
|
Academic Article
|
In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits.
|
Academic Article
|
Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
|
Academic Article
|
CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus.
|
Academic Article
|
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy.
|
Academic Article
|
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
|
Academic Article
|
Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease.
|
Academic Article
|
Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
|
Academic Article
|
Treatment of intestinal worms is associated with decreased HIV plasma viral load.
|
Academic Article
|
Determinants of HIV-1 shedding in the genital tract of women.
|
Academic Article
|
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.
|
Academic Article
|
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.
|
Academic Article
|
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
|
Academic Article
|
Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women.
|
Academic Article
|
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
|
Academic Article
|
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.
|
Academic Article
|
Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women.
|
Academic Article
|
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
|
Academic Article
|
Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART.
|
Academic Article
|
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
|
Academic Article
|
Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.
|
Academic Article
|
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV.
|
Academic Article
|
Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging.
|